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INT RO DUCT IO N
In patients with sepsis and septic shock, the
coagulation and fibrinolytic system are independently
activated. Tissue factor released from endothelial cells
which are stimulated by endotoxin and inflammatory
mediators and the cons umption of natural coagulation
inhibitor antithrombin III, protein C and protein S
activate the coagulation system1- 3 ) . Fibrinolysis is
regulated by both activators and inhibitors released
from endothelial cells4 ) . Although the levels of
plasminogen activator antigen are increased, fibrinolysis
is dominated by increased levels of type 1 plasminogen
activator inhibitor (PAI- 1)5 , 6 ) . This imbalance between
coagulation and fibrinolys is predisposes to the
development of disseminated intravascular coagulation,
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O bje c t iv e s ：T he co ag u lat io n a nd f ib rino ly t ic s y s te m ap p e a rs to b e act iv ate d by
t h e s e p t ic p ro c e s s ind e p e nd e nt ly , le ad ing to t he sy n d ro m e o f d is s e m in ate d
int rav as c u la r co ag u lat io n ( DIC) . In t h is s t udy , w e inv e s t ig ate d t he c h a ng e s w it h in t h e
h e m o s tat ic s y s te m re late d to t he s e v e rity o f t h e illne s s a nd t he p ro g no s is in
p at ie nt s w it h s e p s is .
M e t h o d s ：Plas m a t h ro m b in -a nt it h ro m b in III(T A T ) a nd p las m in -α 2 -a nt ip las m in
( PA P) c o m p le x e s w e re m e as u re d us ing ELIS A m e t ho d s in 3 2 p at ie nt s w it h s e p s is
a nd 2 0 co nt ro ls a nd w e re a na ly z e d a cc o rd ing to t he A PA CHE III s co re s a nd s u rv iv a l
o f t h e p at ie nt s .
Re s u lt s ：Pla s m a TA T a nd PA P in p at ie nt s w it h s e p s is w e re s ig n if ic a nt ly h ig he r
t h a n co nt ro ls . No ns u rv iv o rs s ho w e d g re ate r le v e ls o f T A T (2 1.7 2 2 .3 ng / m L) a nd
lo w e r le v e ls o f PA P(6 28 .4 3 7 8 . 1ng / m L) t ha n s u rv iv o rs (T A T : 1 1. 1 1 1.2 ng / m L;
PA P : 8 5 7 . 1 3 6 4 . 1ng/ m L) . T he im b a la nce b e tw e e n c o ag u lat io n a nd f ib rino ly s is
d e s c rib e d a s T A T/ PA P rat io w as c lo s e ly re la te d w it h A PA CHE III s c o re s in p at ie nt s
w it h s e p s is ( r =0 .4 7) a nd t he T A T/ PA P rat io in no ns u rv iv o rs w a s s ig n if ic a nt ly h ig he r
c o m p a re d w it h s u rv iv o rs (3 4 .4 2 1 .4 v s . 14 .4 13 .8 ) .
Co nc lu s io n：In s e p s is , b o t h c o ag u lat io n a nd t he f ib rino ly s is s y s te m a re act iv ate d
a nd t h e im b a la nc e b e tw e e n c o ag u lat io n a nd f ib rino ly s is p re d is p o s e s to t h e
hy p e rco ag u lat io n s ta te a nd is c lo s e ly re la te d to t h e s e v e rity o f t he d is e a s e a nd t h e
p ro g no s is .
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fibrin deposition and microthrombi. Fibrin depos ition and
complement activation can cause extensive vessel wall
damage and may be associated with multiple organ
failure2 , 3 ) . There have been several clinical studies
concerning biochemical evidence of activation of
coagulation and inhibition of fibrinolysis in sepsis4 , 6 ) .
Thrombin- antithrombin III(TAT) and plasmin-α2 -
antiplasmin(PAP) complexes are known as highly
sensitive and specific markers of coagulation and the
fibrinolytic system7 , 8 ) . Recently, it has been reported
that the imbalance between coagulation and fibrinolysis
described as TAT/PAP ratio leads to mortality and
organ dysfunction in patients with sepsis9 , 10 ) . In this
study, we investigated what kind of changes within the
hemostatic system are related to the severity of illness
and the prognosis in patients with sepsis .
MAT ER IA LS A ND MET HO DS
S ubjects
We prospectively studied 32 patients with sepsis (20
male, 12 female) admitted from August 1996 to J uly
1997. Age (mean ± SD) was 59.4 ± 17.8 years . The
diagnosis of sepsis was according to the criteria
described by the American College of Chest Physician/
Society of Critical Care Medicine(ACCP/SCCM) Con-
sensus Conference held in 19911 1) . The diagnos is of
sepsis was made if two of the four following criteria
were fulfilled: temperature > 38℃ or < 36℃ , respiratory
rate > 20/min or PaCO2 < 32mmHg, white blood cell
count > 12,000/mm3 , or < 4,000/mm3 , or immature
neutrophil > 10% with evidence of infection. The septic
shock was defined as the sepsis- induced hypotens ion
or vasopressor dependency and the presence of signs
of hypoperfusion, such as lactic acidosis , a ltered mental
status or oliguria .
The origins of infection were pulmonary (22), uro-
genital (4), wound (4), and abdominal (2) foci. Bactere-
mia was noted in 9 cases (4 Gram- positive, 5 Gram-
negative organisms), septic shock in 8 cases and acute
respiratory distress syndrome in 5 cases. 12 of 32
patients expired mainly due to multiple organ failure .
The patients with underlying cardiovascular disease,
pregnancy and liver disease, as well as those on
drugs affecting the hemostatic system, such as wafarin,
were excluded. Control values were obtained from 20
healthy volunteers (M:5 F:15, Age: 32.4 ± 5.7 years)
among the laboratory and technical personnel. The age
of the control group was not matched with the patient
group; this limitation may not significantly influence the
result of this study because the fibrinolytic enzyme
activity does not show much variation according to
age, but is only slightly decreased in elderly12 ) .
Clinica l Assess ment
The clinical status of the patients was assessed
using the APACHE III scoring system13 ) . APACHE III
score was obtained within 24hrs after clinical
determination of the sepsis . If more than 3 parameters
were missing, the case was excluded. APACHE III
score of the seps is patients was 60.3±39.0(range: 9 -
176).
Dete rmination of Plas ma TAT and PAP
Blood samples were collected within 24hrs after the
clinical diagnosis of sepsis . Venous blood was collected
in 5- ml tubes (Vacutainer, Becton- Dickinson, Plymouth,
UK) containing 0.5ml sodium citrate(0.13 mol/L). Plas ma
was separated by centrifugation at 1,500 x g for 15
min at 4℃ within 30 min, and stored at -70℃ until
assay. Plasma TAT and PAP were measured by
commercially available test kits according to the
instructions of the manufacturers . Plasma TAT was
measured by a sandwich ELISA (Enzygnost- TAT,
Behringwerke AG, Marburg, FRG) which uses
polyclonal rabbit antibodies against human thrombin and
peroxidase- conjugated antibodies to human antithrombin
III. Plasma PAP was meas ured by a one- step
sandwich ELISA (Enzygnost- PAP, Behringwerke AG,
Marburg, FRG) using monoclonal antibodies (PAP-6)
against human PAP and peroxidase- conjugated
antibodies to plasminogen.
Statistica l Methods
Student's t test and chi- square test were used for
comparison of the mean values in the various groups.
In addition, Pearson's correlation coefficients were
calculated for the different variables. All results with p
values of less than 0.05 were considered as statistically
s ignificant.
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RES ULTS
Plasma TAT a nd PAP in patients with seps is and
controls
Plasma TAT and PAP in 32 patients with sepsis
were 15.1 16.8ng/mL and 771.3 380.3ng/mL and the
values in 20 controls were 2.8 1.1ng/mL and 240.4
69.7ng/mL (Fig. 1, 2). Although plasma TAT and PAP
in patients with sepsis were significantly higher than
those in controls , the TAT/PAP ratio (21.3 19.0,
expressed as TAT/PAP x 1,000) in patients with sepsis
was not significantly different from that (12.3 4.4) in 20
controls .
Re lations hip of plas ma TAT a nd PAP to clinica l
features in patie nts with se ps is .
Plasma TAT and PAP in 20 survivors were 11.1
11.2ng/mL and 857.1 364.1ng/mL and those in 12
nonsurvivors were 21.7 22.3ng/mL and 628.4
378.1ng/mL. The TAT/PAP ratio (34.4 21.4) in
nonsurvivors was significantly higher than that (14.4
13.8) in s urvivors (Fig. 3, 4). Plasma TAT and PAP in
8 patients with shock were 11.3 9.0ng/mL and 602.1
495.0ng/mL and those in 24 patients without shock
were 16.3 18.7ng/mL and 827.7 327.3ng/mL. The
TAT/PAP ratio (27.2 22.5) in patients with shock was
not significantly different from that (20.1 18.5) in
patients without shock. No s ignificant differences in
TAT, PAP and TAT/PAP ratio were s hown according to
the presence of causative organisms , bacteremia, acute
respiratory distress syndrome or other organ failure
(data not shown). APACHE III score (93.5 41.8) in
nonsurvivors was significantly higher than those (38.8
17.6) in s urvivors . In contrast to plasma TAT and PAP,
Plasma TAT/PAP ratio in patients with sepsis was
closely correlated with APACHE III score(r=0.47,
p=0.008)(Fig. 5).
Re lations hip of plas ma TAT a nd PAP to othe r
he mostatic pa ra mete rs .
Plasma TAT was s ignificantly correlated with plasma
PAP (r=0.44, p=0.001) and negatively correlated with
fibrinogen (r=-0.43, p=0.017)(Fig. 6). Dividing the
patients with sepsis into two groups according to the
d- dimer levels , Plasma TAT (20.2 21.7ng/mL) and
PAP(1234.5 1270.0ng/mL) in patients with d- dimer
level equal to or greater than 500ng/mL were
s ignificantly higher than plasma TAT (12.4 13.5ng/mL)
and PAP(626.8 357.0ng/mL) in patients with d- dimer
level less than 500ng/mL.
DIS C US S IO N
Despite the advances in antibiotic therapy and
cardiopulmonary support, sepsis with septic shock
remains as a highly lethal condition In sepsis ,
endotoxin of Gram- negative bacteria and capsular
mucopolysaccharides of Gram- positive bacteria trigger
the inflammatory reaction and hemostatic cascades.
Endothelial cells which are stimulated by endotoxin and
inflammatory mediators , express tissue factor and factor
XII, resulting in activation of the coagulation pathway
and consumption of the natural coagulation inhibitors ,
antithrombin III, protein C and protein S, also activate
Fig . 1. Plasma concentration of TAT in control group
and sepsis patients .
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the coagulation system1 , 2 , 14 ) . Platelets , aggregating to
the endothelial cells damaged by protease or
complement, are actively involved in the coagulation
pathway4 , 15 ) . Fibrinolysis is regulated by both activators
and inhibitors which are released from endothelial cells .
Although the levels of plasminogen activators are
increased following activation of coagulation, fibrinolysis
is relatively impaired compared with the activity of
coagulation, and increased levels of type I plasminogen
activator inhibitor (PAI- 1) is suggested to play this role.
This imbalance between coagulation and fibrinolysis
predisposes to the development of disseminated
intravascular coagulation (DIC), fibrin depos ition and
microthrombi. Fibrin deposition and complement
activation can cause extensive vessel wall damage and
may be associated with multiple organ failure6 , 16 , 17 , 18 ) .
In previous reports , many hemostatic parameters ,
including prothrombin time (PT), partia l thromboplastin
time (PTT), fibrinogen, d- dimer, fibrin degradation
product (FDP), plasminogen and plasminogen activator
inhibitor (PAI), were studied in patients with sepsis and
s howed various activation patterns3 , 4 ) .
Thrombin and plasmin are rapidly neutralized and
stabilized by antithrombin III and α2 - antiplasmin to
form TAT and PAP, res pectively. So, TAT and PAP
are known as stable , accurate and sensitive markers of
coagluation and fibrinolys is system7 , 8 ) . Compared with
FDP, d- dimer and antithrombin III, they have been
known to be more useful parameters in the evaluation
of disseminated intravascular coagulation7 , 8 , 16 ) .
The balance of coagulation and fibrinolysis can be
expressed as TAT/PAP ratio. Some variations of
TAT/PAP ratio from the imbalance between coagulation
and fibrinolysis have been shown according to the
underlying diseases associated with disseminated
Fig . 5 . Correlation between TAT/PAP ratio and APACHE
III score.
Fig . 3 . Plasma concentration of TAT and PAP of survivors and nonsurvivors in sepsis patients .
Fig . 4 . Comparison of TAT/PAP ratio between survivors
and nonsurvivors in sepsis patients .
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intravascular coagulation. The TAT/PAP ratio was high
in seps is , intermediate in solid tumor and low in
hematologic malignancy such as acute promyelocytic
leukemia. High TAT/PAP ratio in patients with sepsis
means excessive activation of coagulation and more
vulnerability to microthrombi, microembolization and
eventual multiple organ failure 16 , 17 ) .
In previous studies, plasma TAT, tissue- type
plas minogen activator (t- PA), urokinase- type
plas minogen activator (u- PA) and PAI- 1 in patients
with sepsis were reported to be elevated17 , 18 ) . Lorente
et al.9 ) reported that plasma TAT had a close
relationship with prognosis , a lthough plasma TAT shows
no s ignificant correlation with APACHE score or
multiple organ failure score, and that higher PAI- 1
contributed to poor outcome.
Recently, Kidokoro et al.10 ) reported that plas ma TAT
and PAP in patients with sepsis were elevated and
high TAT/PAP ratio from the imbalance between
coagulation and fibrinolysis led to the onset of organ
dysfunction. Philippe et al.6 ) reported that plasma PAI- 1
levels in patients with sepsis , caus ing relative
impairment of fibrinolys is , were closely related with the
severity and outcome.
In our study, both TAT and PAP in patients with
sepsis were obviously elevated. It was s hown that the
high TAT/PAP ratio in patients with sepsis was closely
related with APACHE III score and outcome although
the relationship of TAT/PAP ratio with organ dysfunction
was not clearly shown, which might be due to the
small sample size. The suppression of the fibrinolytic
system was more prominent in nonsurvivors than
survivors .
In conclusion, both coagulation and the fibrinolysis
system were activated in patients with sepsis and the
imbalance between coagulation and fibrinolys is is
closely related with the severity and outcome of
patients with sepsis .
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